Law office Zornada has advised DDL Zagreb and its shareholders on the sale of a majority shareholding in the company to Neftys Pharma. Miskovic & Miskovic, BDK Advokati, and ODI Law advised Neftys Pharma.

Anagnostopoulos has successfully represented a former director of Werfen Hellas before the Athens Criminal Court, which cleared the defendant of healthcare fraud charges related to product pricing practices for healthcare organizations.

Rowan Legal has advised CasInvent Pharma on the successful closing of a new investment round. Kristyna & Mikulas advised i&i Prague and Havel & Partners advised the Holecek Family Foundation as the investors. Hladky Legal reportedly advised other investors.

Artificial intelligence (AI) is entering the medical sector more and more boldly, transforming the healthcare system and changing the way patients and doctors communicate and how the process of caring for patients' health looks. One of the most exciting tools of this revolution are medical chatbots – AI-based programmes that support both patients and professionals by automating many tasks and offering personalised assistance.

By Implementing Regulation (EU) 2025/1197, published on Friday, 20 June 2025, the European Commission decided to exclude companies from the People’s Republic of China (PRC) from public contracts for medical devices. This applies to contracts with an estimated value of more than five million euros. Furthermore, no more than 50% of the contract value may be passed on to Chinese companies.

Given the growth of the Bulgarian pharmaceutical retail sector, it is essential to understand the legal framework governing the operation of pharmacies, drugstores, cosmetics counters and optical retailers. Each of these types of businesses is subject to specific regulatory requirements designed to safeguard public health, ensure quality control and maintain compliance with both national and EU legislation.